PVT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Both domestic and foreign studies have found that pvt1 expression is upregulated in patients with CML, and studies have shown [7] that pvt1 silencing leads to cell cycle arrest by negatively regulating the expression of cyclin-dependent kinase inhibitors P15 and P16, thereby inhibiting tumor cell growth.